15 October 2025
Cancers | Highly Cited Papers Related to Thyroid Cancer
We are delighted to share some highly cited papers on thyroid cancer published in 2024 in Cancers (ISSN: 2072-6694).
The list of highly cited papers can be viewed below:
“Improvement in Central Neck Dissection Quality in Thyroid Cancer by Use of Tissue Autofluorescence”
by Octavian Constantin Neagoe and Mihaela Ionică
Cancers 2024, 16(2), 258; https://doi.org/10.3390/cancers16020258
“Association of HOTAIR, MIR155HG, TERC, miR-155, -196a2, and -146a Genes Polymorphisms with Papillary Thyroid Cancer Susceptibility and Prognosis”
by Jelena Karajovic, Bozidar Kovacevic, Bojana Uzelac, Debora Stefik, Bojana Jovanovic, Petar Ristic, Snezana Cerovic and Gordana Supic
Cancers 2024, 16(3), 485; https://doi.org/10.3390/cancers16030485
“How [18F]FDG-PET/CT Affects the Management of Patients with Differentiated Thyroid Carcinoma in Clinical Routines”
by Jonas Vogel, Julia Sekler, Brigitte Gückel, Christina Pfannenberg, Konstantin Nikolaou, Christian La Fougère, Helmut Dittmann and Christian Philipp Reinert
Cancers 2024, 16(3), 588; https://doi.org/10.3390/cancers16030588
“FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature”
by Priscilla Guglielmo, Pierpaolo Alongi, Lucia Baratto, Miriam Conte, Elisabetta Maria Abenavoli, Ambra Buschiazzo, Greta Celesti, Francesco Dondi, Rossella Filice, Joana Gorica et al.
Cancers 2024, 16(4), 839; https://doi.org/10.3390/cancers16040839
“Latest Progress in Risk-Adapted Surgery for Medullary Thyroid Cancer”
by Andreas Machens, Kerstin Lorenz, Tim Brandenburg, Dagmar Führer, Frank Weber and Henning Dralle
Cancers 2024, 16(5), 917; https://doi.org/10.3390/cancers16050917
“Advances in the Development of Positron Emission Tomography Tracers for Improved Detection of Differentiated Thyroid Cancer”
by Hannelore Iris Coerts, Bart de Keizer and Frederik Anton Verburg
Cancers 2024, 16(7), 1401; https://doi.org/10.3390/cancers16071401
“The Utility of Contrast-Enhanced Ultrasound (CEUS) in Assessing the Risk of Malignancy in Thyroid Nodules”
by Agnieszka Żyłka, Katarzyna Dobruch-Sobczak, Hanna Piotrzkowska-Wróblewska, Maciej Jędrzejczyk, Elwira Bakuła-Zalewska, Piotr Góralski, Jacek Gałczyński and Marek Dedecjus
Cancers 2024, 16(10), 1911; https://doi.org/10.3390/cancers16101911
“Current and Future of Robotic Surgery in Thyroid Cancer Treatment”
by Joonseon Park and Kwangsoon Kim
Cancers 2024, 16(13), 2470; https://doi.org/10.3390/cancers16132470
“Pre-Operative Calcitonin and CEA Values May Predict the Extent of Metastases to the Lateral Neck Lymph Nodes in Patients with Medullary Thyroid Cancer”
by Antonio Prinzi, Francesco Frasca, Marco Russo, Gabriella Pellegriti, Tommaso Piticchio, Dario Tumino, Antonino Belfiore and Pasqualino Malandrino
Cancers 2024, 16(17), 2979; https://doi.org/10.3390/cancers16172979
“The Value of Pretherapeutic Basal Calcitonin Cut-Offs for the Therapeutic Strategy and Prediction of Long-Term Outcome of Patients with Medullary Thyroid Cancer—A 30-Year Single-Center Experience”
by Martin B. Niederle, Teresa Binter, Philipp Riss, Bruno Niederle and Christian Scheuba
Cancers 2024, 16(19), 3343; https://doi.org/10.3390/cancers16193343
“Explainable Thyroid Cancer Diagnosis Through Two-Level Machine Learning Optimization with an Improved Naked Mole-Rat Algorithm”
by Wojciech Książek
Cancers 2024, 16(24), 4128; https://doi.org/10.3390/cancers16244128
The list of relevant Special Issues can be viewed below:
|
“Thyroid Cancer: New Advances from Diagnosis to Therapy: 2nd Edition” |
“New Advances and Approaches in Thyroid Cancer” |
 |
 |
You are welcome to submit relevant papers to Cancers.
Cancers Editorial Office
